Cargando…
Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619590/ https://www.ncbi.nlm.nih.gov/pubmed/26492353 http://dx.doi.org/10.1371/journal.pone.0141704 |
_version_ | 1782397137714151424 |
---|---|
author | Ahmadizar, Fariba Onland-Moret, N. Charlotte de Boer, Anthonius Liu, Geoffrey Maitland-van der Zee, Anke H. |
author_facet | Ahmadizar, Fariba Onland-Moret, N. Charlotte de Boer, Anthonius Liu, Geoffrey Maitland-van der Zee, Anke H. |
author_sort | Ahmadizar, Fariba |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4619590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-46195902015-10-29 Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Ahmadizar, Fariba Onland-Moret, N. Charlotte de Boer, Anthonius Liu, Geoffrey Maitland-van der Zee, Anke H. PLoS One Correction Public Library of Science 2015-10-22 /pmc/articles/PMC4619590/ /pubmed/26492353 http://dx.doi.org/10.1371/journal.pone.0141704 Text en © 2015 Ahmadizar et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Correction Ahmadizar, Fariba Onland-Moret, N. Charlotte de Boer, Anthonius Liu, Geoffrey Maitland-van der Zee, Anke H. Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title | Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_full | Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_fullStr | Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_short | Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
title_sort | correction: efficacy and safety assessment of the addition of bevacizumab to adjuvant therapy agents in cancer patients: a systematic review and meta-analysis of randomized controlled trials |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619590/ https://www.ncbi.nlm.nih.gov/pubmed/26492353 http://dx.doi.org/10.1371/journal.pone.0141704 |
work_keys_str_mv | AT ahmadizarfariba correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT onlandmoretncharlotte correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT deboeranthonius correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT liugeoffrey correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials AT maitlandvanderzeeankeh correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials |